Welcome to our dedicated page for INTEST SEC filings (Ticker: INTT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on INTEST's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into INTEST's regulatory disclosures and financial reporting.
inTEST Corp President & CEO Richard N. Grant Jr. reported the forfeiture of 9,859 shares of Common Stock on March 4, 2026 as a disposition to the issuer. A footnote states these shares were forfeited under the terms of Mr. Grant's performance-based restricted stock award granted on March 8, 2023.
After this forfeiture, Mr. Grant directly held 189,216 shares of Common Stock. The filing also lists several Employee Stock Options (rights to buy), with post-transaction holdings of 2,327, 43,384, 30,536, 16,988, 25,692 and 112,000 options, respectively. Footnotes describe option vesting in four equal annual installments commencing on March 17, 2026, March 6, 2025, March 8, 2024, and March 9, 2023, and note that one option grant is fully vested as of the report date.
InTest Corporation reported fourth quarter 2025 revenue of $32.8 million and diluted EPS of $0.10, with gross margin improving to 45.4% and nearly 80% of revenue from non-semiconductor markets. Orders were $37.5 million and year-end backlog reached $53.9 million, up 36.4% from a year earlier.
For full year 2025, revenue declined 12.9% to $113.8 million and the company moved from net earnings of $2.9 million in 2024 to a net loss of $2.5 million, or ($0.21) per diluted share. Adjusted EBITDA fell to $4.0 million from $10.8 million. Management reduced total debt by $7.6 million during 2025 and ended the year with $18.1 million in cash, cash equivalents and restricted cash.
Looking ahead, InTest targets 2026 revenue between $125 million and $130 million, gross margin of about 45%, and operating expenses of $53 million to $55 million. First quarter 2026 revenue is projected at $31 million to $33 million with gross margin of roughly 44%, supported by a stronger backlog and expected recovery in semiconductor demand in the second half.
inTEST Corporation director reports open-market stock purchase. A company director filed a Form 4 disclosing the purchase of 6,000 shares of inTEST common stock on 11/19/2025 at a price of $7.44 per share in a transaction coded as a purchase. Following this buy, the reporting person directly owns 84,057 shares of inTEST common stock. This filing reflects a change in the director's personal ownership stake rather than an issuance of new shares by the company.
inTest Corporation (INTT) reported lower results for Q3 2025. Revenue was $26.236 million versus $30.272 million a year ago, and the company posted a net loss of $0.938 million (basic and diluted EPS $(0.08)) compared with net earnings of $0.495 million (EPS $0.04). Gross profit was $10.992 million versus $14.012 million, and operating loss was $1.193 million versus operating income of $0.487 million.
For the nine months ended September 30, 2025, revenue was $81.003 million versus $94.087 million, with a net loss of $3.770 million versus net earnings of $1.387 million. Operating cash flow strengthened to $8.337 million, supported by a $9.393 million reduction in trade receivables. Cash and cash equivalents were $16.230 million, with $4.867 million classified as restricted cash. Total liabilities were $46.407 million, including current and long-term debt of $6.533 million and $2.336 million. Stockholders’ equity was $101.870 million. Shares outstanding were 12,483,433 as of October 31, 2025.
inTEST Corporation (INTT) furnished a Form 8-K announcing it issued a press release with financial results for the third quarter ended September 30, 2025. The disclosure appears under Item 2.02, Results of Operations and Financial Condition.
The information provided under Item 2.02, including Exhibit 99.1 (2025 Third Quarter Results Press Release dated November 5, 2025), is furnished and not deemed “filed” for purposes of Section 18 of the Exchange Act, and is not incorporated by reference into other filings.
inTEST (NYSE: INTT) filed an 8-K disclosing the voting results of its 2025 Annual Meeting held on June 18, 2025.
Shareholders re-elected all five director nominees, ratified RSM US LLP as independent auditor, and approved the company’s 2024 executive compensation on an advisory basis. Support levels were high—each director received at least 86 % of votes cast; the auditor garnered nearly 99 %.
Investors also indicated a preference for an annual say-on-pay vote (86.7 % in favor). No proposals were rejected, and no other material business items were introduced.